Medical Innovation Exchange

FDA tags Editas' thalassemia cell therapy an orphan drug as it rounds final bend in race to clinic


Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.